Immuneering Corporation (IMRX) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Immuneering Corporation (IMRX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $195.3M, listed on NASDAQ, employing roughly 54 people, carrying a beta of 0.36 to the broader market. Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Led by Benjamin J. Zeskind, public since 2021-07-30.
Snapshot as of May 15, 2026.
- Spot Price
- $5.17
- Total OI
- 9.5K